Ponds Clarant B3 (Teresa Cecena DBA Genesis)
Welcome to the PulseAid listing for the Ponds Clarant B3 drug offered from Teresa Cecena DBA Genesis. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teresa Cecena DBA Genesis |
NON-PROPRIETARY NAME: | AVOBENZONE |
SUBSTANCE NAME: | AVOBENZONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2015-05-26 |
END MARKETING DATE: | 0000-00-00 |
Ponds Clarant B3 HUMAN OTC DRUG Details:
Item Description | Ponds Clarant B3 from Teresa Cecena DBA Genesis |
LABELER NAME: | Teresa Cecena DBA Genesis |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(g/3g) |
START MARKETING DATE: | 2015-05-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69772-615_1702805f-9a79-3204-e054-00144ff8d46c |
PRODUCT NDC: | 69772-615 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE Pharmaceutical Manufacturers / Labelers: